Virtus Investment Advisers’s Fate Therapeutics FATE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q4
Sell
-5,137
Closed -$115K 341
2022
Q3
$115K Buy
+5,137
New +$115K 0.05% 274